Nicole A. Hayde
<p>Nicole Hayde, MD, MS, is a pediatric nephrologist at Children’s Hospital at Montefiore Einstein (CHAM), Medical Director, Pediatric Kidney Transplant Program, Associate Director, Pediatric Nephrology Fellowship Program and Associate Professor, Pediatrics at Montefiore-Einstein. Dr. Hayde’s clinical focus is pediatric renal transplantation, with a particular interest in the role of antibodies in allograft injury.</p><p>After earning her Doctor of Medicine from the University of the West Indies, Mona, Jamaica in 2003, Dr. Hayde completed her residency and chief residency in pediatrics at the University of Miami in 2009. She went on to complete her fellowship in pediatric nephrology at CHAM in 2012. During her fellowship, she was also enrolled in the clinical research training program at Einstein, earning her Master of Science in clinical research methods in 2012.</p><p>Dr. Hayde’s research focus is on the role of donor-specific antibodies in pediatric kidney transplantation and methods to decrease antibody mediated injury. Her findings have been published in several peer-reviewed journals, and have been shared through book chapters, posters and presentations. She is on the editorial board of Frontiers in Pediatrics and is a peer reviewer for several journals including Transplantation, Pediatric Transplantation and Human Immunology. She also serves as a research mentor for fellows interested in kidney transplant research.</p><p>Dr. Hayde is board certified in pediatrics and pediatric nephrology. She has several national roles including the associate councilor of region 9 of United Network of Organ Sharing (UNOS) and the executive committee of the pediatric community of practice of the American Society of Transplantation. She is also a member of several professional organizations including the ASPN and the American Society of Histocompatibility and Immunogenetics.</p>
Samuel V. Gorstein
<p>Samuel Gorstein, MD, is Director, Resident Education, Pediatric Intensive Care Unit (PICU) at the Children’s Hospital at Montefiore Einstein (CHAM) and Assistant Professor, Pediatrics at our Albert Einstein College of Medicine. Dr. Gorstein’s clinical focus is on the care of critically ill infants, children and adolescents, focusing on conditions requiring intensive monitoring, life support and complex interventions, such as respiratory failure, sepsis, trauma and post-surgical recovery.
</p><p>After obtaining a Bachelor of Science in Biophysics from Brown University, Dr. Gorstein attended the University of Massachusetts Medical School, where he received his Doctor of Medicine in 2009. He then began his postgraduate training with an internship and residency in Pediatrics at Baystate Medical Center from 2009 to 2012. In 2015, he completed a fellowship in Pediatric Critical Care at Massachusetts General Hospital. </p><p>Dr. Gorstein oversees resident education in the PICU and has developed a didactic curriculum for residents rotating through the PICU at CHAM. His research aligns with his clinical expertise, and his work has been shared through peer-reviewed publications, invited presentations, abstracts, and poster presentations at professional meetings. </p><p>Dr. Gorstein is board-certified in Pediatrics and Pediatric Critical Care Medicine. He is a member of the American Academy of Pediatrics and the Society of Critical Care Medicine.
</p>
Beatrice Goilav
<p>Pediatric Nephrology, lupus nephritis</p>
Polycystic kidney disease; lupus nephritis; biomarkers of acute kidney injury
The role of microRNAs in the development of lupus nephritis and their role in the modulation of the expression of neutrophil gelatinase-associated lipocalin (NGAL) and as urinary biomarkers of disease activity
<p>Dr. Goilav is a pediatric nephrologist who is board certified in Pediatrics and Pediatric Nephrology. Her research interest is in lupus nephritis. She is currently doing translational research studying the role of very small interfering RNAs, called microRNAs, in the development and progression of lupus nephritis and their detection in human urine samples, as well as their role as biomarkers of disease activity.</p><p>Dr. Goilav graduated from the Faculty of Medicine, University of Basel, Switzerland, and did her internship and residency in pediatrics at Jacobi Medical Center. She completed her fellowship in pediatric nephrology at Mount Sinai School of Medicine. Dr. Goilav speaks <span>German, </span><span>Italian, </span><span>Spanish, </span><span>French, </span>Hebrew, and Romanian. </p><p><br /></p>
Antonio C. Fojas, Jr.
<p>Dr. Antonio Fojas obtained his MD from De La Salle University College of Medicine in the Philippines. He completed his residency in Internal Medicine at Our Lady of Mercy Medical Center in the Bronx and was a General Medicine Fellow and Chief Medical Resident at the same institution.</p><p>After completing his fellowship, Dr. Fojas was appointed Chief of General Medicine Ambulatory Clinic until 2003. Since December 2006 he has been an Associate Program Director of the Internal Medicine Program at Our lady of Mercy Medical Center and now Montefiore Medical Center-Wakefield Campus.</p><p>Dr. Fojas' major interest is Primary Care Medicine both in-patient and out-patient.</p>
Lewis Eisen
<p>Dr. Lewis A. Eisen's research interests include critical care outcomes based research and education research, with specific research interests and clinical expertise in ultrasound, simulation training and airway training.</p>
<p>Dr. Eisen completed his undergraduate work at Johns Hopkins University and graduated from Mount Sinai School of Medicine. He completed residency, including a year as chief medical resident, at Beth Israel Medical Center in Manhattan. He then did a pulmonary and critical care fellowship at Beth Israel as well. Since graduating from fellowship in 2007 he has been a member of the faculty at Einstein/Montefiore, where he is currently Chief of Clinical Affairs. House staff selected him as Outstanding Subspecialty Attending of the Year four times. He is Professor of Medicine. </p>
<p>Dr. Eisen is the author of over 50 peer-reviewed manuscripts. His clinical and research interests include simulation training, critical care ultrasound and crew resource management. He has served as faculty for many regional and national critical care ultrasound courses sponsored by the Greater New York Hospital Foundation and the American College of Chest Physicians.</p>
Marcela Del Rio
Gina N. Cassel
Pediatric Critical Care Medicine
<p>Gina Cassel-Choudhury, DO, is Director, Pediatric Critical Care Medicine Quality & Safety Council, Assistant Medical Director, Patient Safety, and Assistant Professor, Pediatrics and Pediatric Critical Care Medicine at Children’s Hospital at Montefiore (CHAM) and Montefiore Einstein. Her focus at CHAM is a multidisciplinary approach to the introduction and maintenance of quality improvement initiatives which promote patient safety.</p><p>After earning her Bachelor of Science in 2003, Dr. Cassel-Choudhury attended the New York College of Osteopathic Medicine, receiving her Doctor of Osteopathy in 2007. She began her postgraduate training with an internship and residency at North Shore-LIJ, Cohen Children’s Hospital from 2007 to 2010. Following this, she came to CHAM for a three-year fellowship in pediatric critical care, which she completed in 2013.</p><p>Dr. Cassel-Choudhury’s research focus revolves around the standardization, implementation and maintenance of guidelines to optimize patient safety. Such work has included a protocol for enteral feeding of patients on high-flow nasal cannula, a standardized algorithm to prevent iatrogenic drug withdrawal and protocol-driven management of convulsive status epilepticus. She has shared her work through peer-reviewed journals, abstracts and presentations.</p><p>Dr. Cassel-Choudhury is board-certified in general pediatrics and pediatric critical care medicine. She is a member of the American Academy of Pediatrics and the Society of Critical Care, Section on Pediatrics. She is also a member of the Solutions for Patient Safety (SPS) network.</p>
Carolyn Ann Bauer
<p>My goal is to develop a multi-disciplinary care center for patients with stage 3-4 chronic kidney disease. I plan to standardize care based on the recommendations of the kidney disease outcomes quality initiative. A database of information on the patients enrolled in the center will allow me to study factors that effect progression of chronic kidney disease, as well as test interventions to see if they improve kidney function. </p>
Chronic Kidney Disease, Kidney Stones, Polycystic Kidney Disease, Hypertension
Interdisciplinary chronic kidney disease management
<p><ol>
<li>Bauer C, Melamed ML, Hostetter TH. Staging of chronic kidney disease: time for a course correction. J Am Soc Nephrol. 2008 May;19(5):844-6</li>
<li>Melamed ML, Bauer C, Hostetter TH. eGFR: is it ready for early identification of CKD? Clin J Am Soc Nephrol. 2008 Sep;3(5):1569-72. Epub 2008 Jul 30.</li>
<li>Hartel D, Lo Y, Bauer C, Budner N, Howard AA, Floris-Moore M, Harnsten JH, Santoro N, Schoenbaum EE. Attitudes toward menopause in HIV-infected and at-risk women. Clin Interv Aging. 2008;3(3):561-6.</li>
<li>Bauer C, Abramowitz M, Hostetter TH. Is angiotensin system blockade indicated in the elderly? Nat Rev Nephrol. 2010 Jan;6(1):11-2.</li>
</ol></p>
Carolyn Bauer, MD, earned her medical degree at Albert Einstein College of Medicine in 2001. She completed her residency at New York Presbyterian-Cornell and was chief resident at NYU Downtown Hospital. She then completed her Nephrology Fellowship at Albert Einstein College of Medicine. Dr. Bauer is an Associate Professor of Medicine and is board certified by the American Board of Internal Medicine and the American Board of Nephrology. She is a member of the American Society of Nephrology and the National Kidney Foundation.
Praveen Ballabh
<p>Our laboratory studies the pathogenesis of intraventricular hemorrhage (IVH) and evaluates neuro-protective strategies to prevent brain injury after IVH in premature infants. The major projects in our laboratory are focused on determining a) the mechanisms underlying white matter injury in premature infants with IVH and approaches to minimize the damage, b) the effect of IVH on glutamatergic neurogenesis and corticogenesis in the developing brain, and strategies to restore these processes, and c) the effect of prematurity on neurogenesis and corticogenesis.</p>
<p>To answer our research questions, we employ a preterm rabbit model (<em>in vivo</em> studies) and an <em>in vitro</em> organotypic forebrain slice culture model of IVH. Our glycerol model of IVH in preterm rabbits exhibits periventricular white matter injury and post-hemorrhagic hydrocephalus similar to that seen in human preterm survivors with IVH. In addition, we analyze autopsy samples from preterm infants with and without IVH. Commonly used techniques include Immunohistochemistry, confocal microscopy, stereological quantification of neural cells, Western blot analyses, real time qPCR, slice culture, neuronal migration studies, viral gene transfer, flow-cytometry, and magnetic bead isolation of cells.</p>
Effect of prematurity on brain development,
Effect of IVH in interneurons,
Effect of IVH on blood brain barrier development,
Hydrocephalus
<p><strong>Selected Bibliography:</strong></p>
<p style="margin: 0in 0in 8pt 4.5pt; text-align: justify; line-height: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto;"> </p>
<p style="background: #fefefe; margin: 0in; mso-add-space: auto;"><a name="_Hlk65666964"></a><a name="_Hlk63084336"></a><span style="mso-bookmark: _Hlk65666964;"><span lang="EN" style="color: black; font-family: 'Arial',sans-serif; font-size: 10pt; mso-bidi-font-weight: bold; mso-color-alt: windowtext; mso-ansi-language: EN;">1.Krishna S. Cheng B, Sharma D, Yadav S, Ballabh P. PPAR</span></span><a name="_Hlk75795679"></a><span style="mso-bookmark: _Hlk65666964;"><span style="mso-bookmark: _Hlk63084336;"><span lang="EN" style="color: black; font-family: Symbol; font-size: 10pt; mso-fareast-font-family: Calibri; mso-bidi-font-weight: bold; mso-ascii-font-family: Arial; mso-hansi-font-family: Arial; mso-char-type: symbol; mso-symbol-font-family: Symbol; mso-color-alt: windowtext; mso-ansi-language: EN; mso-bidi-font-family: Arial; mso-fareast-theme-font: minor-latin;"><span style="mso-char-type: symbol; mso-symbol-font-family: Symbol;">g</span></span></span></span><span style="mso-bookmark: _Hlk75795679;"><span style="mso-bookmark: _Hlk65666964;"><span style="mso-bookmark: _Hlk63084336;"><span lang="EN" style="color: black; font-family: 'Arial',sans-serif; font-size: 10pt; mso-bidi-font-weight: bold; mso-color-alt: windowtext; mso-ansi-language: EN;"> activation enhances myelination and neurological recovery in premature rabbits with intraventricular hemorrhage</span></span></span></span><span style="mso-bookmark: _Hlk65666964;"><span style="mso-bookmark: _Hlk63084336;"><span lang="EN" style="color: black; font-family: 'Arial',sans-serif; font-size: 10pt; mso-bidi-font-weight: bold; mso-color-alt: windowtext; mso-ansi-language: EN;">. PNAS in press 2021 </span></span></span><span style="mso-bookmark: _Hlk65666964;"><span style="mso-bookmark: _Hlk63084336;"><span style="color: black; font-family: 'Arial',sans-serif; font-size: 10pt;"> </span></span></span></p>
<p style="margin: 0in 0in 8pt 4.5pt; text-align: justify; line-height: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto;"> </p>
<p style="background: #fefefe; margin: 0in;"><span style="mso-bookmark: _Hlk65666964;"><span style="mso-bookmark: _Hlk63084336;"><span lang="EN" style="color: black; font-family: 'Arial',sans-serif; font-size: 10pt; mso-bidi-font-weight: bold; mso-color-alt: windowtext; mso-ansi-language: EN;">2. Ballabh P, de Vries LS. White matter injury in infants with intraventricular haemorrhage: mechanisms and therapies. Nat Rev Neurol. 2021 Apr;17(4):199-214. doi: 10.1038/s41582-020-00447-8. Epub 2021 Jan 27. PMID: 33504979</span></span></span></p>
<p style="margin: 0in 0in 8pt 4.5pt; text-align: justify; line-height: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto;"> </p>
<p style="background: #fefefe; margin: 0in;"><span lang="EN" style="color: black; font-family: 'Arial',sans-serif; font-size: 10pt; mso-color-alt: windowtext; mso-ansi-language: EN;">3. Cheng B, Ballabh P. Recovery of the brain after intraventricular hemorrhage. Semin Fetal Neonatal Med. 2021 Feb 26:101224. doi: 10.1016/j.siny.2021.101224. Online ahead of print. PMID: 33888444</span></p>
<p style="margin: 0in 0in 8pt 4.5pt; text-align: justify; line-height: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto;"> </p>
<p style="margin: 0in;"><span style="color: black; font-family: 'Arial',sans-serif; font-size: 10pt;">4. Klebe D, Tibrewal M, Sharma DR, Vanparthy R, Krishna S, Varghese M Cheng B, Dobrenis K, Hof PR, Ballabh P. Reduced hippocampal dendritic branchign , spine density and neurocognitive function in preamture infants and reversal with estrogen and TrkB agonist treatment. Cerebral Cortex 2019 Dec 17:29912):4832-4947 PMID: 308777</span></p>
<p style="margin: 0in 0in 8pt 4.5pt; text-align: justify; line-height: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto;"> </p>
<p style="background: white; margin: 0in -13.7pt 0in 0in; text-align: justify; tab-stops: 4.5pt;"><span style="color: black; font-family: 'Arial',sans-serif; font-size: 10pt; mso-color-alt: windowtext;">6.. </span><span lang="EN" style="color: black; font-family: 'Arial',sans-serif; font-size: 10pt; mso-color-alt: windowtext; mso-ansi-language: EN;">Dohare <strong>P</strong>, Cheng B, Ahmed E, Yadala V, Singla <strong>P</strong>, Thomas S, Kayton R, Ungvari Z, <strong>Ballabh</strong> <strong>P</strong>. Glycogen synthase 3b inhibition enhances myelination in preterm rabbit newborns with intraventricular hemorrhage, but not recombinant Wnt3A. <strong style="mso-bidi-font-weight: normal;">Neurobiol Dis.</strong> 2018 Jun 22;118:22-39. doi: 10.1016/j.nbd.2018.06.015. <span style="mso-spacerun: yes;"> </span>PMID 29940337</span></p>
<p style="margin: 0in 0in 8pt 4.5pt; text-align: justify; line-height: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto;"> </p>
<p style="background: white; margin: 0in -13.7pt 0in 0in; text-align: justify; tab-stops: 4.5pt;"><span lang="EN" style="color: black; font-family: 'Arial',sans-serif; font-size: 10pt; mso-color-alt: windowtext; mso-ansi-language: EN;">7. Tibrewal M, Cheng B, Dohare <strong>P</strong>, Hu F, Mehdizadeh R, Wang <strong>P</strong>, Zheng D, Ungvari Z, <strong>Ballabh</strong> <strong>P</strong>. Disruption of interneuron neurogemeis in premature newborns and revesal with estrogen treatment. <strong style="mso-bidi-font-weight: normal;">J Neurosci.</strong> 2018 Jan 31;38(5):1100-1113. doi: 10.1523/JNEUROSCI.1875-17.2017. Epub 2017 Dec 15. PMID: 29246927</span></p>
<p style="margin: 0in 0in 8pt 4.5pt; text-align: justify; line-height: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto;"> </p>
<p style="margin: 0in; mso-layout-grid-align: none;"><span lang="EN" style="color: black; font-family: 'Arial',sans-serif; font-size: 10pt; mso-ansi-language: EN;">8. </span><span style="color: black; font-family: 'Arial',sans-serif; font-size: 10pt; mso-bidi-font-weight: bold;">Panda S, Dohare P, Jain S,XParikh N,</span><span style="color: black; font-family: 'Arial',sans-serif; font-size: 10pt;"> <span style="mso-bidi-font-weight: bold;"><span style="mso-spacerun: yes;"> </span>Singla P, Mehdizadeh R,<span style="mso-spacerun: yes;"> </span>Klebe DW,</span> <span style="mso-bidi-font-weight: bold;">Kleinman G,</span> <span style="mso-bidi-font-weight: bold;">X Cheng B, <strong>Ballabh</strong></span><strong style="mso-bidi-font-weight: normal;"> P. </strong><span style="mso-bidi-font-weight: bold;">Estrogen treatment reverses prematurity-induced disruption in cortical interneuron population. <strong>Journal of Neuroscience</strong></span></span><span lang="EN" style="color: black; font-family: 'Arial',sans-serif; font-size: 10pt; mso-ansi-language: EN;">. 2018 Aug 22;38(34):7378-7391. doi: 10.1523/JNEUROSCI.0478-18.2018. Epub 2018 Jul 23. PMID:30037831.</span></p>
<p style="margin: 0in; mso-layout-grid-align: none;"><span style="color: black; font-family: 'Arial',sans-serif; font-size: 10pt; mso-bidi-font-weight: bold; mso-ansi-language: EN;"><span style="mso-spacerun: yes;"> </span></span><span style="color: black; font-family: 'Arial',sans-serif; font-size: 10pt; mso-bidi-font-weight: bold;">(Society of Neuroscience selected this article to </span><span style="color: black; font-family: 'Arial',sans-serif; font-size: 10pt;">highlight the media under embargo).</span></p>
<p style="margin: 0in 0in 8pt 4.5pt; text-align: justify; line-height: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto;"> </p>
<p style="background: white; margin: 0in;"><span style="color: black; font-family: 'Arial',sans-serif; font-size: 10pt; mso-color-alt: windowtext;">9.</span><span lang="EN" style="color: black; font-family: 'Arial',sans-serif; font-size: 10pt; mso-color-alt: windowtext; mso-ansi-language: EN;"> Dohare P, Kidwai A, Kaur J, Singla P, Krishna S, <strong>Klebe</strong> D, Zhang X, Hevner R, <strong>Ballabh</strong> P. GSK3<u>β</u> inhibition restores impaired neurogenesis in preterm neonates with intraventricular hemorrhage. Cereb Cortex. 2018 Sep 6. doi: 10.1093/cercor/bhy217. PMID: 30192926</span></p>
<p style="margin: 0in 0in 8pt 4.5pt; text-align: justify; line-height: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto;"> </p>
<p style="background: #fefefe; margin: 0in; text-align: justify;"><span lang="EN" style="color: black; font-family: 'Arial',sans-serif; font-size: 10pt; mso-color-alt: windowtext; mso-ansi-language: EN;">10.<span style="mso-spacerun: yes;"> </span>Dohare P, Zia MT, Ahmed E, Ahmed A, Yadala V, Schober AL, Ortega JA, Kayton R, Ungvari Z, Mongin AA, <strong>Ballabh P</strong>. AMPA-Kainate Receptor Inhibition Promotes Neurologic Recovery in Premature Rabbits with Intraventricular Hemorrhage. <strong>J Neurosci.</strong> 2016 Mar 16;36(11):3363-77. doi: 10.1523/JNEUROSCI.4329-15.2016. PMID: 26985043</span></p>
<p style="margin: 0in 0in 8pt 4.5pt; text-align: justify; line-height: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto;"> </p>
<p style="background: #fefefe; margin: 0in; text-align: justify;"><span lang="EN" style="color: black; font-family: 'Arial',sans-serif; font-size: 10pt; mso-color-alt: windowtext; mso-ansi-language: EN;">11. Vinukonda G, Dohare P, Arshad A, Zia MT, Panda S, Korumilli R, Kayton R, Hascall VC, Lauer ME, <strong>Ballabh P</strong>. Hyaluronidase and Hyaluronan Oligosaccharides Promote Neurological Recovery after Intraventricular Hemorrhage. <strong>J Neurosci</strong>. 2016 Jan 20;36(3):872-89. doi: 10.1523/JNEUROSCI.3297-15.2016.</span></p>
<p style="margin: 0in 0in 8pt 4.5pt; text-align: justify; line-height: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto;"> </p>
<p style="background: #fefefe; margin: 0in; text-align: justify;"><span lang="EN" style="color: black; font-family: 'Arial',sans-serif; font-size: 10pt; mso-color-alt: windowtext; mso-ansi-language: EN;">12 Vinukonda G, Hu F, Mehdizadeh R. Kayton R, <strong>Ballabh P</strong>. Epidermal growth factor preserves myelin and promotes astrogliosis after intraventricular hemorrhage. <strong>Glia.</strong> 2016 Jul 29. doi: 10.1002/glia.23037. PMID: 27472419</span></p>
<p style="margin: 0in 0in 8pt 4.5pt; text-align: justify; line-height: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto;"> </p>
<p style="background: #fefefe; margin: 0in; text-align: justify;"><span lang="EN" style="color: black; font-family: 'Arial',sans-serif; font-size: 10pt; mso-color-alt: windowtext; mso-ansi-language: EN;">13. Arshad A, Vose LR, Vinukonda G, Hu V, Yoshikawa K, Csiszar A, Brumberg J, <strong>Ballabh P</strong>. Extended production of cortical interneurons into the third trimester of human gestation. <strong>Cerebral cortex</strong>. 2015 Apr 16. PMID: 25882040</span></p>
<p style="margin: 0in 0in 8pt 4.5pt; text-align: justify; line-height: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto;"> </p>
<p style="background: #fefefe; margin: 0in; text-align: justify;"><span lang="EN" style="color: black; font-family: 'Arial',sans-serif; font-size: 10pt; mso-color-alt: windowtext; mso-ansi-language: EN;">14. Vose LR, Vinukonda G, Jo S, Miry O, Diamond D, Korumilli R, Arshad A, Zia MT, Hu F, Kayton RJ, La Gamma EF, Bansal R, Bianco AC, <strong>Ballabh, P</strong>. Treatment with thyroxine restores myelination and clinical recovery after intraventricular hemorrhage. J Neurosci. 2013 Oct 30;33(44):17232-46</span></p>
<p style="margin: 0in 0in 8pt 4.5pt; text-align: justify; line-height: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto;"> </p>
<p style="background: #fefefe; margin: 0in; text-align: justify;"><span lang="EN" style="color: black; font-family: 'Arial',sans-serif; font-size: 10pt; mso-color-alt: windowtext; mso-ansi-language: EN;">15. Malik S, Vinukonda G, Vose LR, Diamond D, Bhimavarapu BB, Hu F, Zia MT, Hevner R, Zecevic N, <strong>Ballabh P</strong>. Neurogenesis continues in the third trimester of pregnancy and is suppressed by premature birth. J Neurosci. 2013 Jan 9;33(2):411-23. PMID: 23303921</span></p>
<p style="margin: 0in 0in 8pt 4.5pt; text-align: justify; line-height: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto;"> </p>
<p style="background: #fefefe; margin: 0in; text-align: justify;"><span lang="EN" style="color: black; font-family: 'Arial',sans-serif; font-size: 10pt; mso-color-alt: windowtext; mso-ansi-language: EN;">16. Dummula K, Vinukonda G, Chu P, Xing Y, Hu F, Mailk S, Csiszar A, Chua C, Mouton P, Kayton RJ, Brumberg JC, Bansal R,<strong> Ballabh P</strong>. Bone morphogenetic protein inhibition promotes Neurological recovery after intraventricular hemorrhage. J Neurosci. 2011 Aug 24;31(34):12068-82. PubMed. PMID:21865450; PubMed Central PMCID: PMC3167068.</span></p>
<p style="margin: 0in 0in 8pt 4.5pt; text-align: justify; line-height: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto;"> </p>
<p style="background: #fefefe; margin: 0in; text-align: justify;"><span lang="EN" style="color: black; font-family: 'Arial',sans-serif; font-size: 10pt; mso-color-alt: windowtext; mso-ansi-language: EN;">17. Vinukonda G, Csiszar, A, Hu F, Dummula K, Pandey NK, Zia MT, Ferreri, NR, Ungvari, Z, LaGamma, EF, <strong>Ballabh, P</strong>. Neuroprotection in intraventricular hemorrhage by cox-2 inhibition: EP1 receptor and TNF-α are downstream mediators of brain injury. Brain 2010 Aug;133(Pt 8):2264-802.</span></p>
<p style="margin: 0in 0in 8pt 4.5pt; text-align: justify; line-height: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto;"> </p>
<p style="background: #fefefe; margin: 0in; text-align: justify;"><span lang="EN" style="color: black; font-family: 'Arial',sans-serif; font-size: 10pt; mso-color-alt: windowtext; mso-ansi-language: EN;">18. Chua C, Chahboune H, Braun A, Dummula K, Chua CE, Yu J, Ungvari Z, Sherbany A, Hyder F, <strong>Ballabh P</strong>. Consequences of intraventricular hemorrhage in a rabbit pup model. Stroke 2009 Oct;40(10):3369-77.</span><span lang="EN" style="color: black; font-family: 'Arial',sans-serif; font-size: 10pt; mso-ansi-language: EN;"> </span></p>
<p style="margin: 0in 0in 8pt 4.5pt; text-align: justify; line-height: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto;"> </p>
<p style="background: #fefefe; margin: 0in; text-align: justify;"><span lang="EN" style="color: black; font-family: 'Arial',sans-serif; font-size: 10pt; mso-color-alt: windowtext; mso-ansi-language: EN;">19. Vinukonda G. Csiszar, A. Hu F, Dummula K, Pandey NK, Zia MT, Ferreri, NR, Ungvari, Z, LaGamma, EF, <strong>Ballabh, P</strong>. Effect of prenatal glucocorticoid on the vasculature of the developing brain. Stroke. 2010 Aug;41(8):1766-73. PubMed PMID:20616316; PubMed Central PMCID: PMC2920046.</span></p>
<p style="margin: 0in 0in 8pt 4.5pt; text-align: justify; line-height: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto;"> </p>
<p style="background: #fefefe; margin: 0in; text-align: justify;"><span lang="EN" style="color: black; font-family: 'Arial',sans-serif; font-size: 10pt; mso-color-alt: windowtext; mso-ansi-language: EN;">20. <strong>Ballabh P</strong>, Xu H, Hu F, Xu H, Braun A, Ungvari Z. Csiszar A, Goldman S, Nedergaard M. Angiogenic inhibition reduced germinal matrix hemorrhage. Nature Medicine 2007 Apr;13(4):477-85. (Cover page article).</span><span lang="EN" style="color: black; font-family: 'Arial',sans-serif; font-size: 10pt; mso-ansi-language: EN;"> </span></p>
<p style="margin: 0in 0in 8pt 4.5pt; text-align: justify; line-height: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto;"> </p>
<p style="background: #fefefe; margin: 0in; text-align: justify;"><span lang="EN" style="color: black; font-family: 'Arial',sans-serif; font-size: 10pt; mso-color-alt: windowtext; mso-ansi-language: EN;">21. Braun A, Xu H, Kocherlakota P, Siegel D, Ungvari Z. Csiszar A , Nedergaard M, <strong>Ballabh P</strong>. Paucity of pericytes in germinal matrix vasculature. J Neurosci 2007 Oct 31; 27(44):12012-12024.</span></p>
<p style="margin: 0in 0in 8pt 4.5pt; text-align: justify; line-height: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto;"> </p>
<p style="background: #fefefe; margin: 0in; text-align: justify;"><strong><span lang="EN" style="color: black; font-family: 'Arial',sans-serif; font-size: 10pt; mso-color-alt: windowtext; mso-ansi-language: EN;">22. Ballabh P</span></strong><span lang="EN" style="color: black; font-family: 'Arial',sans-serif; font-size: 10pt; mso-color-alt: windowtext; mso-ansi-language: EN;">, Braun A, Nedergaard M. Recent insights in blood brain barrier: an overview. Structure, regulation, modulating factors and clinical implications. Neurobiology of Disease 2004;16:1-13.</span></p>
<p style="margin: 0in 0in 8pt 4.5pt; text-align: justify; line-height: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto;"> </p>
<p style="margin: 0in 0in 8pt 4.5pt;"> </p>
<p style="margin: 0in 0in 8pt 4.5pt;"> </p>
<p> </p>
<p>Praveen Ballabh, MD, is an attending neonatologist, Professor of Pediatrics and Neuroscientist at Children’s Hospital at Montefiore and Montefiore-Einstein. For more than two decades, Dr. Ballabh’s clinical focus has been in neonatology, working in level IV NICUs. His research is focused on intraventricular hemorrhage (IVH) and he has made major contribution to the field. In fact, he has been one of the known world leaders in the field of IVH research.</p><p>In 1980, Dr. Ballabh completed his MD degree in Pediatrics in 1984 from the Institute of Medical Sciences in Varanasi, India. His postdoctoral training included a yearlong pediatric residency at Christ Hospital Medical Center in Oak Lawn, Illinois, which he completed in 1997, followed by a yearlong pediatric critical care fellowship at Children’s Hospital of Michigan. From 1998 to 2001, he pursued his neonatology fellowship at NewYork-Presbyterian Hospital, Cornell University.</p><p>Dr. Ballabh’s career goal is to transform the quality of life of survivors with IVH by bringing novel ideas from bench to bedside. His work as a translational and clinical scientist has already contributed immensely to this field. He is director of a basic science laboratory located at the Kennedy Center, where he studies mechanisms of brain injury produced by IVH and evaluates neuro-protective strategies to prevent damage after IVH in animal models ( <a href="https://ballabhlab.einsteinmedneuroscience.org/" target="_blank">https://ballabhlab.einsteinmedneuroscience.org/</a>). His research is funded by National Institute of health, foundations, and industry for about two decades. He shares his discoveries and findings through publication in peer-reviewed journals, invited presentations, book chapters and abstracts. He has also been a reviewer for several journals including <em>Nature Medicine, Brain, Journal of Neuroscience, EMBO, Stroke, Developmental Neuroscience, the Journal of Neuroscience Research</em>, and others.</p><p>Dr. Ballabh is board-certified in neonatal-perinatal medicine by the American Board of Pediatrics. He is a member of the Society of Pediatric Research, the Society of Neuroscience, the American Heart Association and the American Stroke Association.</p>